| Name | Title | Contact Details |
|---|
Chambrel At Williamsburg is a Williamsburg, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Westphalia Retirement Ctr is a Westphalia, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ConsumerMedical is a leading healthcare decision support and concierge company serving approximately 3 million individuals through some of the nation`s largest employers` health plans and private exchanges. As a Medical Ally` ConsumerMedical guides participants throughout their healthcare journey with compassionate` high-touch support and deep clinical expertise. ConsumerMedical offers a fully integrated suite of solutions including Medical Decision Support` Expert Medical Opinions` Claims Advocacy and more` helping individuals and families navigate the healthcare system while reducing unnecessary elective surgeries and driving patients to the highest quality providers. The result is better care for patients` more empowered healthcare decisions for employees and their families` and a better bottom line for business. Headquartered outside Boston in Pembroke` MA` ConsumerMedical employs over100 people.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.
At Medcillary, we provide the latest ancillary products and services that benefit patients and healthcare providers to meet and exceed their unique needs. We are passionate about developing innovative, ground-breaking tests, products and tools to enhance patient care, provide value to our clients, and transform information into knowledge and insights. Our goal is to advance the development and delivery of healthcare and consumer products by providing the highest quality testing possible. Mission: Medcillary was founded with two key principles in place: compliance and clinical relevance with a focus on offering superior and innovative healthcare products aligned to meet the needs of the physicians in our communities, while leading the way for business development and operational excellence through honesty and integrity with our strategic partners. Our vision is to be the most successful and respected medical ancillary solution company in the world. Our core values are: - Commitment - Integrity - Transparency - Pursuit of Excellence - Customer Focus - Respect